Critics of the pharmaceutical industry have long complained that drugmakers use high research and development costs as an excuse for their sky-high prices. A new study from a coalition of health care...

Forty-three states are suing some of the largest generic drug manufacturers in the U.S., accusing them of conspiring to inflate prices for more than 100 widely-used medications, including antibiotics...

The health care debate has Democrats on Capitol Hill and the presidential campaign trail facing renewed pressure to make clear where they stand: Are they for “Medicare for All”? Or will they take up...